Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IOTC | Common Stock | Other | -$49K | -408K | -100% | $0.12* | 0 | Dec 27, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IOTC | Stock Options (right to buy) | Other | $0 | +800K | +66.67% | $0.00 | 2M | Dec 27, 2021 | Common Stock | $0.12 | Direct | F1, F2, F3 | |
transaction | IOTC | Stock Options (right to buy) | Award | $0 | +750K | $0.00 | 750K | Dec 8, 2020 | Common Stock | $0.12 | Direct | F4 |
Id | Content |
---|---|
F1 | On December 27, 2021, the Reporting Person rescinded the shares of common stock acquired via the cashless exercise on May 21, 2021. Pursuant to the Stock Option Rescission Agreement between the issuer and the Reporting Person, the 408,163 shares of common stock that were issued to the Reporting Person as a result of the May 2021 Option Exercise were returned to the issuer, and the 800,000 options that relate to the rescission and return of these shares were reinstated as vested and available for future exercise by the Reporting Person as part of the original 2,000,000 options that were granted to the Reporting Person as referenced under footnote 3. |
F2 | On May 21, 2021, the Reporting Person exercised, via a cashless exercise, stock options to acquire 800,000 shares of common stock of the issuer, at the exercise price of $0.12 per share. In connection with the cashless exercise of these stock options, the issuer withheld options to acquire 391,837 shares common stock of the issuer to satisfy the exercise price and issued to the Reporting Person the remaining 408,163 shares of common stock. |
F3 | On December 9, 2019, options to purchase an aggregate of 2,000,000 shares of common stock of the issuer were granted to the Reporting Person. Pursuant to the Stock Option Modification Agreement between the issuer and the Reporting Person, these options became fully vested on December 8, 2020, with 50% of the stock options exercisable at the exercise price of $0.12 per share; 25% of the stock options exercisable at the exercise price of $0.25 per share; and the remaining 25% of the stock options exercisable at the exercise price of $0.35 per share. |
F4 | On December 8, 2020, and in connection with his annual bonus, the Reporting Person was granted fully vested options with anti-dilution provisions to acquire 750,000 shares (or approximately 0.25% of then outstanding shares) of the issuer's common stock at the exercise price of $0.12 per share. |